Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Nimer

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Leukemia|April 4, 2008
Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation: models for the 'second hit' hypothesisH Becker, D Pfeifer, J D Afonso, et al.
Blood|October 25, 2001
Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemiaJ G Jurcic, S D Nimer, D A Scheinberg, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 16, 2011
Consolidation with bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic AL amyloidosisH Landau, H Hassoun, C Bello, et al.
Bone Marrow Transplantation|September 18, 2003
Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphomaT Kewalramani, S D Nimer, A D Zelenetz, et al.
Bone Marrow Transplantation|August 1, 1996
Infectious complications of autologous bone marrow and peripheral stem cell transplantation for refractory leukemia and lymphomaJ D Nosanchuk, K A Sepkowitz, R N Pearse, et al.
The Journal of Biological Chemistry|August 16, 2001
Cyclin A-dependent phosphorylation of the ETS-related protein, MEF, restricts its activity to the G1 phase of the cell cycleY Miyazaki, P Boccuni, S Mao, et al.
Blood|January 1, 1995
Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantationR L Paquette, N Tebyani, M Frane, et al.
Molecular and Cellular Biology|March 1, 1994
Characterization of a cell-type-restricted negative regulatory activity of the human granulocyte-macrophage colony-stimulating factor geneJ K Fraser, J J Guerra, C Y Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remissionG J Schiller, S D Nimer, M C Territo, et al.
Blood|June 1, 1995
A phase I trial of recombinant human interleukin-6 in patients with myelodysplastic syndromes and thrombocytopeniaM S Gordon, J Nemunaitis, R Hoffman, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Leukemia|April 4, 2008
Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation: models for the 'second hit' hypothesisH Becker, D Pfeifer, J D Afonso, et al.
Blood|October 25, 2001
Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemiaJ G Jurcic, S D Nimer, D A Scheinberg, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 16, 2011
Consolidation with bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic AL amyloidosisH Landau, H Hassoun, C Bello, et al.
Bone Marrow Transplantation|September 18, 2003
Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphomaT Kewalramani, S D Nimer, A D Zelenetz, et al.
Bone Marrow Transplantation|August 1, 1996
Infectious complications of autologous bone marrow and peripheral stem cell transplantation for refractory leukemia and lymphomaJ D Nosanchuk, K A Sepkowitz, R N Pearse, et al.
The Journal of Biological Chemistry|August 16, 2001
Cyclin A-dependent phosphorylation of the ETS-related protein, MEF, restricts its activity to the G1 phase of the cell cycleY Miyazaki, P Boccuni, S Mao, et al.
Blood|January 1, 1995
Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantationR L Paquette, N Tebyani, M Frane, et al.
Molecular and Cellular Biology|March 1, 1994
Characterization of a cell-type-restricted negative regulatory activity of the human granulocyte-macrophage colony-stimulating factor geneJ K Fraser, J J Guerra, C Y Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remissionG J Schiller, S D Nimer, M C Territo, et al.
Blood|June 1, 1995
A phase I trial of recombinant human interleukin-6 in patients with myelodysplastic syndromes and thrombocytopeniaM S Gordon, J Nemunaitis, R Hoffman, et al.
Pageof 9